Expression of Semaphorin-3A and its receptors in endochondral ossification: potential role in skeletal development and innervation.
Bone tissue is densely innervated, and there is increasing evidence for a neural control of bone metabolism. Semaphorin-3A is a very important regulator of neuronal targeting in the peripheral nervous system as well as in angiogenesis, and knockout of the Semaphorin-3A gene induces abnormal bone and cartilage development. We analyzed the spatial and temporal expression patterns of Semaphorin-3A signaling molecules during endochondral ossification, in parallel with the establishment of innervation. We show that osteoblasts and chondrocytes differentiated in vitro express most members of the Semaphorin-3A signaling system (Semaphorin-3A, Neuropilin-1, and Plexins-A1 and -A2). In vitro, osteoclasts express most receptor chains but not the ligand. In situ, these molecules are all expressed in the periosteum and by resting, prehypertrophic and hypertrophic chondrocytes in ossification centers before the onset of neurovascular invasion. They are detected later in osteoblasts and also osteoclasts, with differences in intensity and regional distribution. Semaphorin-3A and Neuropilin-1 are also expressed in the bone marrow. Plexin-A3 is not expressed by bone cell lineages in vitro. It is detected early in the periosteum and hypertrophic chondrocytes. After the onset of ossification, this chain is restricted to a network of cell processes in close vicinity to the cells lining the trabeculae, similar to the pattern observed for neural markers at the same stages. After birth, while the density of innervation decreases, Plexin-A3 is strongly expressed by blood vessels on the ossification front. In conclusion, Semaphorin-3A signaling is present in bone and seems to precede or coincide at the temporal but also spatial level with the invasion of bone by blood vessels and nerve fibers. Expression patterns suggest Plexin-A3/Neuropilin-1 as a candidate receptor in target cells for the regulation of bone innervation by Semaphorin-3A.
Gomez
C
C
INSERM, Unit 403, Lyon, France.
Burt-Pichat
B
B
Mallein-Gerin
F
F
Merle
B
B
Delmas
P D
PD
Skerry
T M
TM
Vico
L
L
Malaval
L
L
Chenu
C
C
D000818:Animals; D001846:Bone Development; D001853:Bone Marrow / Q000378:metabolism; D001842:Bone and Bones / Q000294:innervation / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D002460:Cell Line; D019070:Cell Lineage; D019902:Chondrocytes / Q000166:cytology* / Q000378:metabolism; D017931:DNA Primers / Q000737:chemistry; D005269:Femur / Q000378:metabolism; D005786:Gene Expression Regulation; D007150:Immunohistochemistry; D008024:Ligands; D051379:Mice; D009419:Nerve Tissue Proteins / Q000096:biosynthesis; D009474:Neurons / Q000378:metabolism; D039942:Neuropilin-1 / Q000096:biosynthesis; D010006:Osteoblasts / Q000378:metabolism; D010010:Osteoclasts / Q000378:metabolism; D016133:Polymerase Chain Reaction; D051381:Rats; D011956:Receptors, Cell Surface / Q000096:biosynthesis*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D040121:Semaphorin-3A / Q000096:biosynthesis* / Q000235:genetics*; D015398:Signal Transduction; D013997:Time Factors
D017931:DNA Primers; D008024:Ligands; D009419:Nerve Tissue Proteins; C492114:Plxna1 protein, mouse; C492113:Plxna2 protein, mouse; C492112:Plxna3 protein, mouse; D011956:Receptors, Cell Surface; D040121:Semaphorin-3A; D039942:Neuropilin-1